New Health Technologies: A UK Perspective Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies".
Int J Health Policy Manag
; 6(12): 721-722, 2017 12 01.
Article
en En
| MEDLINE
| ID: mdl-29172379
ABSTRACT
New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Evaluación de la Tecnología Biomédica
/
Tecnología Biomédica
Tipo de estudio:
Guideline
/
Health_technology_assessment
Aspecto:
Patient_preference
Límite:
Humans
País/Región como asunto:
Europa
Idioma:
En
Revista:
Int J Health Policy Manag
Año:
2017
Tipo del documento:
Article
País de afiliación:
Reino Unido